Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 229 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2018-08-21 | 2018-09-28 | 58594 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2019-08-07 | 2019-08-19 | 91091 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2020-04-06 | 2020-05-04 | 111060 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-02-12 | 2021-03-15 | 133991 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-05-28 | 2021-07-09 | 140075 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2021-08-13 | 2021-08-31 | 144142 |
| APO-NALTREXONE | 50MG | TABLET | Resolved | 2023-01-06 | 2023-03-30 | 180119 |
| APO-NAPRO-NA | 275MG | TABLET | Resolved | 2018-05-15 | 2018-10-05 | 49499 |
| APO-NAPRO-NA | 275MG | TABLET | Resolved | 2022-06-06 | 2022-08-22 | 162077 |
| APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71139 |
| APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2017-05-24 | 2018-10-05 | 11082 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2017-10-03 | 2018-03-01 | 24274 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-02-26 | 2018-07-18 | 41142 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-03-27 | 2018-04-10 | 44111 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-05-31 | 2018-08-14 | 50961 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-08-09 | 2018-10-26 | 57799 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69305 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69312 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-12-12 | 2018-12-27 | 69315 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
| APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
| APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
| APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
| APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
| APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
| APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
| APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
| APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
| APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
| APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |